&nbsp;

Drugs Used:

capivasertib,

fulvestrant

Quick Link(s):

Regimen Monograph

Oct 2025

Regimen

PACL

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

PACLitaxel

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma

Drugs Used:

riTUXimab

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

NIVL

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - Relapsed Classical Hodgkin Lymphoma (cHL) Post-Autologous Stem Cell Transplant (ASCT) or ASCT Ineligible

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

NIVL

Cancer Type:

Head and Neck

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck which is Platinum Resistant or Refractory

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

SACI

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Sacituzumab Govitecan - Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer

New Drug Funding Program

Sacituzumab Govitecan - HR-positive HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer

Drugs Used:

sacituzumab govitecan

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

NIVL(MNT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

MVAC(HD)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

DOXO

Cancer Type:

Gynecologic,

Endometrial

Intent: Palliative

Drugs Used:

DOXOrubicin

Quick Link(s):

Regimen Monograph

Oct 2023

Regimen

CISPGEMC

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Drugs Used:

gemcitabine,

CISplatin

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Jan 2024

Regimen

PACL

Cancer Type:

Unknown Primary

Intent: Palliative

Drugs Used:

PACLitaxel